You searched for "funding"

2820 results found

Are corneal guttata an additional risk factor in complicated cataract surgery needing a future corneal transplant?

This registry-based cohort study from Sweden utilised data from the Swedish National Cataract Registry and the Swedish Cornea Transplant Registry. Patients who underwent phacoemulsification with a posterior intraocular lens between 2010 and 2012 numbered 192,476. Of these cases, 288 underwent...

One-week intubation in external dacryocystorhinostomy

Whether to routinely intubate or not in dacryocystorhinostomy (DCR) surgery has been a subject of controversy among lacrimal surgeons. Similarly, if intubated the timing of removal of stent is not standard. Here, the authors carried out a survey of their...

Trabeculectomy with MMC in post-traumatic angle recession glaucoma

This study aimed to evaluate the outcomes of primary trabeculectomy with mitomycin-C (trab MMC) in phakic eyes with post-traumatic angle recession glaucoma with no prior intraocular surgery. Thirty-two phakic eyes of 32 patients who underwent trab MMC between January-2002 and...

Clinical features of basic acquired nonaccommodative esotropia requiring surgery

Basic acquired nonaccommodative esotropia (BANAET) is a concomitant esotropia occurring after the age of six months without significant refractive error or accommodative element. Esotropia is similar for both near and distance and children have prior binocular single vision. The purpose...

Clinical outcomes following intraluminal stent removal from the PAUL glaucoma implant

This single German centre retrospective cohort study included 70 eyes from 68 patients. Qualified and complete success rates (95% CI) were 92.9% and 55.7% after 1 year and 88.6% (81.4–95.7%) and 50% (37.1–62.9%) at the last follow-up time point for...

A retrospective study of the use of Dermis Fat Grafts for orbital volume augmentation

The authors describe the outcomes of 173 primary Dermis Fat Grafts (DFGs) and 66 secondary DFGs. Median follow-up for the primary group was 21.5 months and 14 months for the secondary group. Outcome measures included: prosthesis motility, prosthesis fit, patient...

Welcome from Guest Editor Evelyn Mensah

I loved attending RCOphth Annual Congress face-to-face in Glasgow this year. How wonderful it was to see old friends and meet new after two pandemic years. At Congress I chaired the session on ‘Racism in the NHS’ with ‘three professors’...

Toxoplasmosis and the associated retinochoroiditis: important facts and when to treat

Annie SeeWah Tung provides an overview of toxoplasmosis retinochoroiditis, including guidance on which cases should be treated and the treatment options. Toxoplasmosis retinochoroiditis is an infectious condition that is characterised by retinochoroidal lesions commonly in the posterior pole and is...

Being more consistent with screening for convergence insufficiency

This prospective cases series aimed to identify the average values and sensitivity of clinical measurements of convergence to aid diagnosis of convergence insufficiency (CI). Children and adults presenting over a two-year period with symptoms including diplopia when reading, headache with...

Piloting myopic control glasses effects on axial length under mesopic conditions

This study aimed to pilot whether axial length reduces when being treated with myopia control glasses in mesopic conditions. Participants were required to have single-vision glasses with spherical equivalent between -1.00 and -5.00 dioptres, astigmatism less than -1.00 dioptre, a...

How to get a trainee from 0 to 600 cataracts in two years: Perspectives from the trainee and the trainer

Trainee’s perspective I remember my first day as an ST1 at Moorfields Eye Hospital in Croydon. I was in theatre for a cataract list, and the challenges were numerous. From draping to hydrating the wound, it was all completely new...

Biotech Healthcare Successfully Concludes Global Phakic Users Meeting 2024 in Barcelona

October 3, 2024 – Celebrating its 25th anniversary, Biotech Healthcare hosted the Global Phakic Users Meeting 2024 at the stunning Joan Miró Foundation in Barcelona on 5th September. Bringing together over 150 ophthalmologists from 28 countries, the event showcased Biotech's...